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Abstract
Background: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) have been shown to be useful for diagnosis
of prosthetic hip and knee infection. Little information is available on CRP and ESR in patients undergoing revision or
resection of shoulder arthroplasties or spine implants.
Methods/Results: We analyzed preoperative CRP and ESR in 636 subjects who underwent knee (n=297), hip (n=221) or
shoulder (n=64) arthroplasty, or spine implant (n=54) removal. A standardized definition of orthopedic implant-associated
infection was applied. Receiver operating curve analysis was used to determine ideal cutoff values for differentiating infected
from non-infected cases. ESR was significantly different in subjects with aseptic failure infection of knee (median 11 and
53.5 mm/h, respectively, p=,0.0001) and hip (median 11 and 30 mm/h, respectively, p=,0.0001) arthroplasties and spine
implants (median 10 and 48.5 mm/h, respectively, p=0.0033), but not shoulder arthroplasties (median 10 and 9 mm/h,
respectively, p=0.9883). Optimized ESR cutoffs for knee, hip and shoulder arthroplasties and spine implants were 19, 13, 26,
and 45 mm/h, respectively. Using thesecutoffs,sensitivityand specificityto detect infection were 89 and 74%for knee, 82 and
60% for hip, and 32 and 93% for shoulder arthroplasties, and 57 and 90% for spine implants. CRP was significantly different in
subjects with aseptic failure and infection of knee (median 4 and 51 mg/l, respectively, p,0.0001), hip (median 3 and 18 mg/l,
respectively, p,0.0001), and shoulder (median 3 and 10 mg/l, respectively, p=0.01) arthroplasties, and spine implants
(median 3 and 20 mg/l, respectively, p=0.0011). Optimized CRP cutoffs for knee, hip, and shoulder arthroplasties, and spine
implants were 14.5,10.3,7,and4.6mg/l, respectively. Using thesecutoffs,sensitivityand specificitytodetect infectionwere79
and 88% for knee, 74 and 79% for hip, and 63 and 73% for shoulder arthroplasties, and 79 and 68% for spine implants.
Conclusion: CRP and ESR have poor sensitivity for the diagnosis of shoulder implant infection. A CRP of 4.6 mg/l had a
sensitivity of 79 and a specificity of 68% to detect infection of spine implants.
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Introduction
C-reactive protein (CRP), and erythrocyte sedimentation rate
(ESR) are inexpensive, non-invasive tests that are often obtained in
subjects with orthopedic implants prior to implant removal to
assess for implant-associated infection. CRP and, to a lesser extent,
ESR, have been shown to be useful in the diagnosis of prosthetic
hip and knee infection, especially if validated cut-off values are
applied (Table 1). Little information is available, however, on CRP
and ESR in patients undergoing revision or resection of shoulder
arthroplasties or spine implants.
ESR and CRP have poor sensitivity to detect prosthetic
shoulder infection when cutoffs of 30 mm/h or 10 mg/l,
respectively, are applied [1]. This may relate to the frequent
implication of the low virulence organism, Propionibacterium acnes,i n
shoulder arthroplasty infection [1,2], or to failure to use optimized
cutoff values for shoulder arthroplasty infection. There is little data
available on the performance of CRP and ESR in the diagnosis of
spine implant-associated infection, although Hahn et al. reported
that normal CRP and ESR do not rule out late infection associated
with spinal instrumentation [3].
We analyzed preoperative CRP and ESR in subjects prior to
implant removal at our institution, using a standardized definition
of orthopedic implant-associated infection, to determine the
sensitivity and specificity of CRP and ESR, using receiver
operating curve analysis-optimized cutoffs, for the diagnosis of
hip, knee, and shoulder arthroplasty and spine implant-associated
infection.
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Study Population
Patients who underwent prosthetic knee, hip, or shoulder
arthroplasty or spine implant removal between July 2001 and June
2008 at Mayo Clinic Rochester, Minnesota, were studied. CRP
(mg/l) and ESR (mm/h) within one month before the index
surgery were analyzed. (If more than one measurement was
available, the measurement closest to surgery was studied.) Some
patients reported herein have been previously described [1,4,5].
Patients without both CRP and ESR performed within one month
before the index surgery were excluded. Patients with underlying
inflammatory arthritides were excluded. This study was reviewed
and approved by the Mayo Clinic Institutional Review Board.
Waivers of informed consent and HIPAA authorization were
approved. For subjects residing in Minnesota, only those who had
authorized use of their medical record in research (Minnesota
Statute 144.335) were included.
Patient Classification
Patients were classified as having orthopedic implant-associated
infection if at least one of the following was present: (1) Visible
purulence surrounding the implant; (2) acute inflammation on
histopathologic examination of permanent tissue sections (as
determined by the clinical pathologist); (3) a sinus tract
communicating with the implant; or (4) positive periprosthetic
tissue culture and positive sonicate fluid culture for the same
microorganism [6]. Aseptic failure was defined as implant failure
not meeting these criteria.
Specimen Collection
Venous blood was collected in a 3.5 ml serum separator tube for
CRP and in a 2.4 ml sodium citrate (0.6 ml) tube for ESR.
Intraoperative tissue samples with the most obvious inflammatory
changes were collected for histopathologic evaluation and
conventional microbiologic culture. Removed implants were
placed in an autoclaved (132uC, 27 psi for 15 minutes) 1 liter
polypropylene wide mouth container (Nalgene, Lima, Ohio).
Specimens were cultured within six hours.
Peri-Implant Tissue Culture
Peri-implant tissue cultures were performed in the Mayo Clinic
Clinical Microbiology Laboratory. Tissue specimens were homog-
enized in 3 ml brain heart infusion broth for 1 minute. The
homogenate was inoculated onto aerobic blood, chocolate, and
anaerobic blood agar and into thioglycollate broth (BD Diagnostic
Systems, Sparks, MD). Aerobic and anaerobic agar plates were
incubated at 35–37uC in 5–7% CO2 aerobically and anaerobically
for 2–4 and 7 days, respectively. Thioglycollate broth was
incubated anaerobically at 35–37uC for 7 days; turbid broth was
subcultured. Microorganisms were identified using routine micro-
biologic techniques. Peri-implant tissue culture positivity was
defined as isolation of the same organism from at least two tissue
specimens from the index surgery.
Sonicate Fluid Culture
Sterile Ringer’s solution (400 ml) was added to each implant-
containing container. The container was vortexed for 30 seconds

















*, **** Knee 145 $2 2 . 5 9 38 37 1 9 6
Spangehl [19].
** Hip 171 .30 82 85 58 95
Austin [20]
***** Knee 296 .30 82 85 58 95
Schinsky [21]
*** Hip 235 .30 97 39 42 96
Bare ´ [22] Knee 295 .30 63 55 39 77
Bernard [23] Hip/knee 171 $30 87 47 94 26
Levitsky [24] Hip/knee 72 .30 60 65 25 90
Feldman et al. [25] Hip/knee 33 .50 79 78 Not reported Not reported
CRP Greidenaus [8]
*, **** Knee 145 $1 3 . 5 9 18 67 4 9 5
Bottner [26]
* Hip/knee 78 .32 95 96 91 98
Spangehl [19]
** Hip 142 .10 96 92 74 99
Austin [20]
***** Knee 296 .10 96 92 74 99
Schinsky [21]
*** Hip 235 .100 94 71 59 96
Bare ´ [22] Knee 295 .10 60 63 45 76
Bernard [23] Hip/knee 228 $10 97 81 98 71
Fink [27] Knee 145 . 13.5 73 81 59 89
Mu ¨ller [28] Hip 50 .5 9 56 28 8 8 0
Virolainen [29] Hip/knee 68 .10 79 68 Not reported Not reported
*Diagnostic cutoff level determined using receiver operating characteristic curve analysis.
**Patients with connective-tissue disorders were excluded from analysis.
***Patients with a preoperative diagnosis of inflammatory arthritis were excluded from analysis.
****Patients with a systemic disease or a condition that could result in an abnormal ESR or CRP, such as rheumatoid arthritis or other inflammatory arthritides, were
excluded from analysis.
*****Patients with a confounding factors that can elevate inflammatory markers (inflammatory disorders, collagen vascular disease, urinary tract infection, hepatitis,
demyelinating neuropathy or malignancy), were excluded from analysis.
doi:10.1371/journal.pone.0009358.t001
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by bath sonication (frequency 4062 kHz, power density
0.2260.04 watts/cm
2) in an Aquasonic Model 750T ultrasound
bath (VWR Scientific, Weschester, PA) for 5 minutes, and then
vortexed again for 30 seconds.
For subjects studied before December 14, 2005, 0.5 ml of
sonicate fluid was directly plated onto aerobic and anaerobic sheep
blood agar plates which were incubated at 35–37uC in 5–7% CO2
aerobically and anaerobically for 5 and 7 days, respectively. For
subjects studied after December 14, 2005, a concentration step
and an extended period of anaerobic incubation were added.
Sonicate fluid was placed into conical centrifuge tubes which were
centrifuged at 3,1506g for 5 minutes. The supernatant was
aspirated (for a one hundred fold concentration) and 0.1 ml of the
sediment was plated onto aerobic and anaerobic sheep blood agar
plates which were incubated at 35–37uC in 5–7% CO2 aerobically
and anaerobically for 2–4 and 14 days, respectively. Microorgan-
isms were enumerated and identified using routine microbiologic
techniques. Sonicate fluid cultures were considered positive based
on the following criteria. A cutoff value of at least 5 colony forming
units (cfu) per plate was applied to the subjects studied before
December 14, 2005. A cutoff value of at least 20 cfu per plate was
applied to the subjects enrolled after December 14, 2005. The
higher cutoff for subjects after December 14, 2005 was used due to
the addition of a concentration step to the sonicate fluid culture
procedure yielding higher numbers of microorganisms [1].
C-Reactive Protein
CRP measurements were performed using the Roche/Hitachi
Modular System. Briefly, the anti-CRP antibodies coupled to latex
microparticles react with antigen to form antigen-antibody
complexes. After agglutination, the complex formation was
measured turbidimetrically. The linear range of detection was 3
to 200 mg/l.
Erythrocyte Sedimentation Rate
The ESR was determined using the Westergren method. The
rate of sedimentation of erythrocytes is measured in a 1:5 dilution
of 3.2% sodium citrate solution to whole blood. Blood is drawn up
in a column and allowed to sit undisturbed for one hour. The
sedimentation is read as the millimeter distance from the top of the
column to the meniscus of the erythrocyte sediment.
Statistical Analysis
Descriptive summaries were reported as median values (due to
the non Gaussian distribution of the data). ESR and CRP levels
between the aseptic failure and the infection groups at the various
anatomic locations (knees, hips, shoulders, spine) were compared
using the Wilcoxon rank sum test. All tests were two sided; a p-
value of less than 0.05 was considered as statistically significant.
Analysis was performed using Statistical Analysis Software (SAS)
version 9.0. Receiver operating characteristic curves for ESR and
CRP were established for knee, hip, and shoulder arthroplasty and
spine implant patients, with the optimal cut-off values chosen as
those in the upper left corner of the curve, representing the point
at which the greatest sensitivity and specificity are achieved.
Funding Source
There was no external funding source.
Results and Discussion
636 subjects who underwent knee (n=297), hip (n=221) or
shoulder (n=64) arthroplasty, or spine implant (n=54) removal
were analyzed. 487 subjects with knee (n=215), hip (n=187), or
shoulder (n=45) arthroplasties and spine implants (n=40)
removed met the preoperative definition of aseptic failure. 149
subjects who underwent removal of knee (n=82), hip (n=34), or
shoulder (n=19) arthroplasties or spine implants (n=14) met the
preoperative definition of orthopedic implant-associated infection.
CRPwas significantlydifferent insubjectswithaseptic failure and
infection of knee (median 4 and 51 mg/l, respectively, p,0.0001),
hip (median 3 and 18 mg/l, respectively, p,0.0001), and shoulder
(median 3 and 10 mg/l, respectively, p=0.01) arthroplasties, and
spine implants (median 3 and 20 mg/l, respectively, p=0.0011).
ESR was significantly different in subjects with aseptic failure and
infection of knee (median 11 and 53.5 mm/h, respectively,
p,0.0001) and hip (median 11 and 30 mm/h, respectively,
p,0.0001) arthroplasties, and spine implants (median 10 and
48.5 mm/h, respectively, p=0.0033), but not shoulder arthroplas-
ties (median 10 and 9 mm/h, respectively, p=0.9883) (Table 2).
The sensitivities, specificities, positive and negative predictive
values, and the p-value from logistic regression of CRP .10 mg/l,
ESR .30 mm/h, and CRP .10 mg/l or ESR .30 mm/h to
detect infection of knee, hip, and shoulder arthroplasties, and
spinal implants are shown in Table 3. The combination of normal
Table 2. Descriptive summary and comparison of aseptic failure versus orthopedic implant-associated infection subjects. Median
(range) values are shown.
Knee arthroplasty (n=297) Aseptic failure (n=215) Orthopedic implant-associated infection (n=82) P-value
ESR, mm/h 11 (0–68) 53.5 (6–128) ,0.0001
CRP, mg/l 4 (0.1–174) 51 (3–444) ,0.0001
Hip arthroplasty (n=221) Aseptic failure (n=187) Orthopedic implant-associated infection (n=34)
ESR, mm/h 11 (0–94) 30 (3–137) ,0.0001
CRP, mg/l 3 (0.3–141) 18 (3–288) ,0.0001
Shoulder arthroplasty (n=64) Aseptic failure (n=45) Orthopedic implant-associated infection (n=19)
ESR, mm/h 10 (0–32) 9 (1–71) 0.9883
CRP, mg/l 3 (3–26) 10 (3–40) 0.01
Spine implant (n=54) Aseptic failure (n=40) Orthopedic implant-associated infection (n=14)
ESR, mm/h 10 (0–74) 48.5 (1–83) 0.0033
CRP, mg/l 3 (0.5–183) 20 (3–205) 0.0011
doi:10.1371/journal.pone.0009358.t002
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infection in 94, 94 and 91% of subjects undergoing knee or hip
arthroplasty or spine implant removal, respectively, but only 77%
of those subjects undergoing shoulder arthroplasty removal.
Optimized ESR cutoffs for knee, hip and shoulder arthroplasties
and spine implants were 19, 13, 26, and 45 mm/h, respectively.
Using these cutoffs, sensitivity and specificity to detect infection
were 89 and 74% for knee, 82 and 60% for hip, and 32 and 93%
for shoulder arthroplasties, and 57 and 90% for spine implants
(Table 4).
Optimized CRP cutoffs for knee, hip, and shoulder arthroplas-
ties, and spine implants were 14.5, 10.3, 7, and 4.6 mg/l,
respectively. Using these cutoffs, sensitivity and specificity to
detect infection were for 79 and 88% knee, 74 and 79% for hip,
and 63 and 73% for shoulder arthroplasties, and 79 and 68% for
spine implants (Table 4).
Our study is a comprehensive analysis of CRP and ESR in
subjects undergoing orthopedic implant removal with and without
infection. In patients satisfying the definition for orthopedic
implant-associated infection, CRP and ESR values were higher
in knee arthroplasty and spine implant patients than in hip
arthroplasty patients. Previous investigations have reported high-
erCRP and ESR values in knee than hip arthroplasty patients with
infection [7].
We used receiver operating curve analysis to optimize CRP and
ESR cutoffs. The optimized CRP cutoff value for hip arthroplasty
infection was similar to the standard cutoff of CRP .10 mg/l
often used in clinical practice. Optimized CRP and ESR cutoff
Table 3. Sensitivity and specificity of CRP (.10 mg/l) and/or ESR (.30 mm/h) for the detection of infected knee, hip and shoulder
arthroplasty and spinal instrumentation.





Knee ESR .30 mm/h 71 (58/82) 89 (191/215) 71 (58/82) 89 (191/215) 0.80 ,0.0001
Knee CRP .10 mg/d 83 (68/82) 79 (170/215) 60 (68/113) 92 (170/184) 0.81 ,0.0001
Knee ESR .30 mm/h or CRP .10 mg/l 87 (71/82) 75 (161/215) 57 (71/125) 94 (161/172) 0.81 ,0.0001
Hip ESR .30 mm/h 47 (16/34) 84 (158/187) 36 (16/45) 90 (158/176) 0.66 ,0.0001
Hip CRP .10 mg/l 74 (25/34) 78 (146/187) 38 (25/66) 94 (146/155) 0.76 ,0.0001
Hip ESR .30 mm/h or CRP .10 mg/l 76 (26/34) 71 (132/187) 32 (26/81) 94 (132/140) 0.74 ,0.0001
Shoulder ESR .30 mm/h 16 (3/19) 98 (44/45) 75 (3/4) 73 (44/60) 0.57 0.0764
Shoulder CRP .10 mg/l 42 (8/19) 84 (38/45) 53 (8/15) 78 (38/49) 0.63 0.0269
Shoulder ESR .30 mm/h or CRP .10 mg/l 42 (8/19) 82 (37/45) 50 (8/16) 77 (37/48) 0.62 0.0455
Spine ESR .30 mm/h 64 (9/14) 83 (33/40) 56 (9/16) 87 (33/38) 0.73 0.0021
Spine CRP .10 mg/l 57 (8/14) 85 (34/40) 57 (8/14) 85 (34/40) 0.71 0.0038
Spine ESR .30 mm/h or CRP .10 mg/l 79 (11/14) 75 (30/40) 52 (11/21) 91 (30/33) 0.77 0.0013
doi:10.1371/journal.pone.0009358.t003
Table 4. Sensitivity and specificity of optimized CRP and ESR for the detection of infected knee, hip and shoulder arthroplasty and
spinal instrumentation.





Knee ESR .19 mm/h 89 (73/82) 74 (159/215) 57 (73/129) 95 (159/168) 0.82 ,0.0001
Knee CRP .14.5 mg/l 79 (65/82) 88 (189/215) 71 (65/91) 92 (189/206) 0.84 ,0.0001
Knee ESR .19 mm/h
or CRP .14.5 mg/l
94 (77/82) 69 (149/215) 54 (77/143) 97 (149/154) 0.82 ,0.0001
Hip ESR .13 mm/h 82 (28/34) 60 (113/187) 27 (28/102) 95 (113/119) 0.71 ,0.0001
Hip CRP .10.3 mg/l 74 (25/34) 79 (147/187) 38 (25/65) 94 (147/156) 0.76 ,0.0001
Hip ESR .13 mm/h
or CRP .10.3 mg/l
88 (30/34) 55 (103/187) 26 (30/114) 96 (103/107) 0.72 ,0.0001
Shoulder ESR .26 mm/h 32 (6/19) 93 (42/45) 67 (6/9) 76 (42/55) 0.63 0.02
Shoulder CRP .7 mg/dl 63 (12/19) 73 (33/45) 50 (12/24) 83 (33/40) 0.68 0.01
Shoulder ESR .26
mm/h or CRP .7 mg/dl
63 (12/19) 73 (33/45) 50 (12/24) 83 (33/40) 0.68 0.01
Spine ESR .45 mm/h 57 (8/14) 90 (36/40) 67 (8/12) 86 (36/42) 0.74 0.001
Spine CRP .4.6 mg/dl 79 (11/14) 68 (27/40) 46 (11/24) 90 (27/30) 0.73 0.01
Spine ESR .45 mm/h or CRP
4.6 mg/dl
79 (11/14) 67 (27/40) 46 (11/24) 90 (27/30) 0.73 0.01
doi:10.1371/journal.pone.0009358.t004
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.19 mm/h, similar to the $13.5 mg/l and $22.5 mm/h values
derived by Greidenaus et al. using a similar approach [8].
Overall, CRP and ESR showed the lowest sensitivity for
diagnosis of shoulder arthroplasty infection, even applying cutoffs
optimized using receiving operating curve analysis. This may
relate to the predominance of P. acnes in shoulder arthroplasty
infection [1,2].
Several investigators have examined the natural history of post-
operative ESR and CRP after uncomplicated arthroplasty. CRP
levels change more rapidly than ESR levels, and return to normal
more rapidly following primary total knee or hip arthroplasty
[7,9]. CRP levels usually peak on the second or third day following
total hip or knee arthroplasty [10,11,12,13], thereafter dropping to
preoperative levels by the third week in total hip arthroplasty
patients and by the end of the second month in total knee
arthroplasty patients [7,14,15]. CRP levels rise to a higher level
postoperatively in total knee than hip arthroplasty patients [11]. A
similar rise and fall of CRP is noted postoperatively in total hip or
knee arthroplasty patients with underlying rheumatoid arthritis
[16]. One study demonstrated that, after uncomplicated arthro-
plasty, ESR peaks on the fifth postoperative day [13], dropping
close to preoperative levels at the end of the third month in total
hip arthroplasty patients, and at the end of the ninth month in
total knee arthroplasty patients [7]. Other studies suggest,
however, that the ESR, although usually normal by six months
postoperatively, may be elevated for as long as one year after
uncomplicated total hip arthroplasty [14,15].
For patients undergoing uncomplicated spinal surgery, investi-
gators have described ESR peaking earlier than described above,
on the fourth day, and normalizing within a two week period in
the majority of patients [17]. Additionally, levels in patients
undergoing fusion surgery were higher than in those patients
undergoing herniated disc removal [17]. In patients with known
vertebral osteomyelitis the ESR may be elevated for a prolonged
period of time, even in the face of appropriate non-operative
treatment [18]. In the referenced series, many patients went on to
a successful clinical outcome in spite of the elevated ESR,
illustrating the poor specificity of the test when used alone to
predict treatment failure [18]. The current study differs in that the
ESR was used in a predictive fashion preoperatively, in
conjunction with the CRP, and a consistent definition of infection
was applied.
In a series of 202 revision total hip arthroplasties, all subjects
with infection had an elevated ESR (.30 mm/h) or CRP
(.10 mg/l) [19]. In our study, this was not the case.
There are several limitations of our study. ESR and CRP are
nonspecific markers of inflammation and may be elevated by
chronic inflammatory conditions (e.g., rheumatoid arthritis),
surgical intervention, or systemic illness. Patients with underlying
inflammatory arthritides were excluded from our study, but we did
not assess for recent surgeries or systemic illnesses not involving the
joint. We assessed ESR and CRP within the month prior to
surgery, at a time when the study subjects had symptoms related to
implant failure. Ideally, the timing of ESR and CRP measurement
should be standardized (e.g., 24 hours prior to surgery). A final
limitation is the lack of a Gold standard definition for prosthetic
shoulder and spine implant infection.
In conclusion, CRP and ESR values are higher in knee
arthroplasty and spine implant patients than in hip arthroplasty
patients with infection, and show the lowest sensitivity for
diagnosis of shoulder arthroplasty infection, even applying cutoffs
optimized using receiving operating curve analysis.
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